Marwa Abdel‐Motaal, Saad Shaaban, Samia S. Hawas, Asma M. Elsharif, Marwa Sharaky, Fatema Suliman Alatawi, Mohamed E. Eissa, Arwa Omar Al Khatib, Prof. Hany M. Abd El-Lateef, Medhat Asem, Ahmed A. Al-Karmalawy
< 10 µM), highlighting the broader therapeutic relevance of this scaffold. Collectively, these data position 6g as a compelling multi-target anticancer lead that integrates apoptosis induction, cell-cycle regulation, and angiogenesis suppression-supporting its potential for development as a next-generation broad-spectrum anticancer agent.